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Abstract
Carbon monoxide (CO) is an endogenous messenger that suppresses inflammation, modulates apoptosis and promotes
vascular remodeling. Here, microarrays were employed to globally characterize the CO (250 ppm) suppression of early (1 h)
LPS-induced inflammation in human monocytic THP-1 cells. CO suppressed 79 of 101 immediate-early genes induced by
LPS; 19% (15/79) were transcription factors and most others were cytokines, chemokines and immune response genes. The
prototypic effects of CO on transcription and protein production occurred early but decreased rapidly. CO activated p38
MAPK, ERK1/2 and Akt and caused an early and transitory delay in LPS-induced JNK activation. However, selective inhibitors
of these kinases failed to block CO suppression of LPS-induced IL-1b, an inflammation marker. Of CO-suppressed genes, 81%
(64/79) were found to have promoters with putative NF-kB binding sites. CO was subsequently shown to block LPS-induced
phosphorylation and degradation of IkBa in human monocytes, thereby inhibiting NF-kB signal transduction. CO broadly
suppresses the initial inflammatory response of human monocytes to LPS by reshaping proximal events in TLR4 signal
transduction such as stress kinase responses and early NF-kB activation. These rapid, but transient effects of CO may have
therapeutic applications in acute pulmonary and vascular injury.
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Introduction
Carbon monoxide (CO), an endogenous messenger generated
by heme oxygenase-1 (HO-1) [1], has cytoprotective [2,3], anti-
proliferative [4–6], and anti-inflammatory effects [7–10] that
indicate a potential for clinical applications. In animal models, CO
itself or CO-releasing molecules (CORMs) have demonstrated
benefits in ischemia/reperfusion injury [11–13], pulmonary
inflammation [8,14,15], and sepsis [10,16]. However, the
intermediary targets of CO signaling and mechanisms of its
therapeutic effects are not entirely clear. Unlike nitric oxide (NO
N),
CO only weakly activates soluble guanylate cyclase [4] and
therefore cGMP may be less important as a second messenger.
The anti-inflammatory effects of CO have been extensively
investigated in rodents. CO was shown in mice to activate p38
MAPK and induce IL-10, thereby downregulating proinflamma-
tory cytokines such as TNF-a, IL-1b and MIP-1b [7]. A study in
rats reported that CO blocks inflammatory responses through
cGMP-dependent inhibition of ERK and suppression of early
growth factor (EGR)-1, an immediate-early transcription factor
[17]. The anti-inflammatoryeffects ofCOhave alsobeen associated
with an early delay in LPS-induced JNK activation and subsequent
impairment of AP-1 signaling [18]. Other investigations have
emphasized CO interference with NF-kB signal transduction
[16,19–22]. Alternatively, CO has been shown to block apoptosis
by activating NF-kB [23,24]. Release of oxygen radicals from
mitochondria was identified as a proximal signaling event in CO
activation of NF-kB [24], as well as CO effects on p38 MAPK [25],
peroxisome proliferator-activated receptor gamma (PPARc) [26]
and hypoxia-inducible factor (HIF-a) [27]. Conversely, other work
has associated the anti-inflammatory activity of CO with NADPH
oxidase inhibition and decreased oxygen radical generation[20,28].
Collectively, these findings in rodents suggest a complex, compart-
mentalized pattern of signaling that appears to be highly dependent
on experimental conditions and timing.
Studies using human cells are more limited, but also
demonstrate a range of effects and similarly indicate that CO
signal transduction may be context dependent. In A549 cells, a
human pulmonary epithelial line, CO gas (250 ppm) inhibited IL-
17-induced activation of ERK1/2 and had no effect on p38
MAPK or JNK[29]. Somewhat differently, CO was shown in
Caco-2 cells (an adenocarcinoma line), to decrease cytokine-
induced activation of p38 MAPK, JNK and ERK1/2 as well as
NF-kB, [21]. Another group also reported that CO suppressed
NF-kB activation in LPS-challenged human umbilical vein
endothelial cells (HUVEC), attenuating the induction of intercel-
lular adhesion molecule-1 (ICAM-1) and nitric oxide synthase 2
(NOS2) expression [30]. Again suggesting that CO may decrease
PLoS ONE | www.plosone.org 1 December 2009 | Volume 4 | Issue 12 | e8139NAPDH oxidase function and ROS production, CO was found to
dampen the respiratory burst in human neutrophils [31].
However, inhaled CO gas (500 ppm) failed to reduce LPS-
induced inflammation in human volunteers, despite substantial
anti-inflammatory effects in LPS-challenged mice [32]. Thus,
human compared to rodent studies show both overlap and
differences. Defining the mechanisms, kinetics and targets of CO
signaling in human cells is essential to understanding its
therapeutic potential.
The goals of this investigation were to identify the earliest gene
targets of CO signaling in human monocytes and to examine its
mechanisms. Oligonucleotide microarrays were used to globally
characterize the effects of CO on Toll-like-receptor (TLR) 4-
mediated gene regulation 1 h after LPS challenge in human THP-
1 cells. Pivotal target genes and signal transduction events were
subsequently verified in primary human monocytes. The predom-
inant effect of CO was to suppress LPS-induced immediate-early
genes including transcription factors, cytokines and chemokines.
Suppression of gene transcription was rapid, but also transient.
Several LPS-responsive stress kinase pathways, p38 MAPK,
ERK1/2 and Akt, were activated by CO, while LPS-induced
JNK phosphorylation was briefly delayed. However, kinase
inhibitors failed to block CO-suppression of IL-1b, indicating that
effects on these pathways were tangential rather than causative.
Most of the genes suppressed by CO were associated with NF-kB
regulation and CO was shown to interfere with an early step in
LPS/TLR4 mediated NF-kB activation in human monocytes.
The mechanism and kinetics of inflammatory response suppres-
sion by CO has implications for its use as a therapeutic strategy.
Materials and Methods
Reagents
Salmonella minnesota Re595 LPS was obtained from List Biologic
(Campbell, CA). Cyclic nucleotide analogue, 8-bromo cGMP was
purchased from Sigma Aldrich (St. Louis, MO). MAPK inhibitors:
p38 (SB-203580), ERK (PD-98059), JNK Inhibitor II and Akt
(LY-294002) were obtained from Calbiochem (San Diego, CA).
Antibodies against phospho-IkB-a (5A5), p38 MAPK, ERK1/2,
JNK, Akt and IL-1b were purchased from Cell Signaling
Technology (San Jose, CA). Santa Cruz Biotechnology (Santa
Cruz, CA) was the source of anti-IkB-a (C-21), anti-Tubulin and
anti-Ah Receptor (C-18) antibodies, as well as double stranded
NF-kB oligonucleotide consensus sequence and mutant NF-kB
oligonucleotide. Anti-rabbit and anti-mouse IgG secondary
antibodies were from Jackson ImmunoResearch Laboratories
(West Grove, PA). RNeasy kits were obtained from Qiagen
(Valencia, CA). ELISA kits for IL-1b and IL-8 were purchased
from R&D Systems (Minneapolis, MN).
Cell Culture
THP-1 cells (TIB-202), a human monocytic cell line, from
American Type Culture Collection (ATCC, Manassas, VA) were
cultured in RPMI-1640 complete medium (Invitrogen, Carlsbad,
Table 1. Validation of microarray results by qRT-PCR in THP-1 cells and primary monocytes.
Gene Symbol Gene Name Entrez ID Fold Change (LPS+CO/LPS)
{
THP-1
(Microarray)
THP-1
(qRT-PCR)
Primary Monocytes
(qRT-PCR)
IL1B interleukin 1, beta 3553 0.35 (0.30–0.40) 0.48 (0.38–0.59) 0.66 (0.54–0.81)
IL8 interleukin 8 3576 0.71 (0.62–0.81) 0.75 (0.68–0.82) 0.73 (0.61–0.88)
ICAM1 intercellular adhesion molecule 1 3383 0.63 (0.58–0.68) 0.70 (0.65–0.76) 0.49 (0.42–0.58)
CXCL1* chemokine (C-X-C motif) ligand 1 (melanoma
growth stimulating activity, alpha)
2919 0.61 (0.54–0.70) 0.71 (0.66–0.76) 0.51 (0.43–0.61)
CXCL2 chemokine (C-X-C motif) ligand 2 2920 0.62 (0.55–0.70) 0.51 (0.44–0.58) 0.66 (0.57–0.78)
CXCL3* chemokine (C-X-C motif) ligand 3 2921 0.48 (0.43–0.54) 0.62 (0.53–0.72) 0.50 (0.44–0.56)
CCL3* chemokine (C-C motif) ligand 3 /// chemokine
(C-C motif) ligand 3-like 1 )
414062 0.62 (0.53–0.73) 0.60 (0.45–0.80) 0.69 (0.60–0.78)
CCL4 chemokine (C-C motif) ligand 4 6351 0.38 (0.30–0.46) 0.55 (0.43–0.70) 0.58 (0.39–0.87)
CCL5 chemokine (C-C motif) ligand 5 6352 0.57 (0.51–0.64) 0.57 (0.48–0.68) 0.68 (0.57–0.80)
CCL20 chemokine (C-C motif) ligand 20 6364 0.43 (0.36–0.52) 0.55 (0.48–0.62) 0.42 (0.27–0.66)
EGR2* early growth response 2 1959 0.35 (0.30–0.41) 0.44 (0.35–0.56) 0.81 (0.76–0.86)
EGR3* early growth response 3 1960 0.45 (0.38–0.53) 0.51 (0.38–0.68) 0.61 (0.45–0.82)
EGR4* early growth response 4 1961 0.58 (0.50–0.67) 0.55 (0.42–0.72) 0.33 (0.22–0.48)
PTGS2 prostaglandin-endoperoxide synthase 2 5743 0.47 (0.41–0.54) 0.46 (0.36–0.58) 0.55 (0.45–0.68)
PTX3* pentraxin-related gene, induced by IL-1 beta 5806 0.58 (0.53–0.65) 0.70 (0.55–0.89) 0.71 (0.64–0.79)
TNF tumor necrosis factor 7124 0.52 (0.46–0.59) 0.72 (0.64–0.81) 0.74 (0.69–0.79)
TNFAIP3* tumor necrosis factor, alpha-induced protein 3 7128 0.58 (0.50–0.68) 0.67 (0.52–0.87) 0.57 (0.50–0.66)
ATF3 activating transcription factor 3 467 0.67 (0.59–0.75) 0.87 (0.72–1.05) 0.76 (0.68–0.86)
NFKBIA nuclear factor of kappa light polypeptide gene
enhancer in B-cells inhibitor, alpha
4792 0.82 (0.71–0.93) 0.54 (0.42–0.69) 1.07 (0.99–1.15)
PDE4B* phosphodiesterase 4B, cAMP-specific 5142 0.60 (0.56–0.64) 0.69 (0.64–0.75) 0.62 (0.48–0.80)
*New candidate genes for CO suppression.
{One standard error confidence interval shown in parentheses.
doi:10.1371/journal.pone.0008139.t001
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vated fetal calf serum, 100 U/ml penicillin, 100 mg/ml strepto-
mycin, and 50 mM b-mercaptoethanol (Sigma-Aldrich) at 37uCi n
a humidified atmosphere of 5% CO2. Human elutriated
monocytes from healthy donors were obtained from the NIH
Clinical Center Department of Transfusion Medicine (Bethesda,
MD) using an IRB-approved protocol. Monocytes were then spun
at 1500 rpm for 5 min and resuspended in Erythrocyte lysis buffer
(Qiagen). Cell pellets were washed twice in PBS buffer,
resuspended in RPMI 1640 complete medium and incubated
overnight. More than 95% of these cells expressed CD14, as
determined by flow cytometry using fluorescein isothiocyanate-
labeled anti-human CD14 (BD Biosciences, San Jose, CA).
LPS Challenge and Carbon Monoxide Exposure
LPS (1 mg/ml) was used as indicated to stimulate THP-1 cells or
elutriated primary human monocytes. Incubated cells were exposed
to CO at 250 ppm in special modular incubator chambers (Billups-
Rothenberg Inc., CA) using premixed gas cylinders (Praxair,
Bethlehem, PA) containing compressed air and 250 ppm CO
supplemented with 5% CO2 for adjustment of pH. Final CO levels
were monitored using a mini CO analyzer (MSA, Pittsburg, PA).
CO exposure time was varied according to the experimental design.
To ensure that gene suppression was not due to CO cytotoxicity,
cell viability was verified by quantifying live cells using a
nucleocounter (New Brunswick Scientific, Edison, NJ).
Oligonucleotide Microarrays
Total RNA extracted from THP-1 cells was subjected to gene
expression profiling using HGU133 plus 2.0 arrays according to
manufacturer’s protocols (Affymetrix, Santa Clara, CA). THP-1 cells
(1610
7) incubated with or without LPS (1 mg/ml) in presence or
absence of CO (250 ppm) were lysed with RLT buffer (Qiagen) and
shredded (Qiashredder column). Total RNA was extracted using
RNeasy Mini kit (Qiagen), following the manufacturer’s instructions.
Quality of total RNA was evaluated using RNA 6000 Nano LabChip
(Agilent 2100 Bioanalyzer, Santa Clara, CA). All samples had intact
18S and 28S ribosomal RNA bands with RIN numbers from 8.8 to
9.4 and RNA 260/280 ratios between 1.9 and 2.0. Double-stranded
cDNA was synthesized from total RNA (1.7 mg) and purified using a
GeneChip Expression 39- One-Cycle cDNA Synthesis kit (Affyme-
trix). Biotin labeled cRNA was made using an IVT GeneChip
Expression 39-Amplification kit (Affymetrix), fragmented and hybrid-
ized to microarrays following the manufacturer’s directions. After
staining with streptavidin-phycoerythrin (SAPE) and anti-streptavidin
antibody (Affymetrix Fluidics Station 400), microarrays were scanned
(Affymetrix 7G) and results (Affymetrix GCOS 1.4) were transferred
to the NIHLIMS database. Raw data and processed data are
available through the National Center for Biotechnology Information
Gene Expression Omnibus database (Accession no. GSE16193) and
all data is MIAME compliant.
Quantification of Cytokines
THP-1 cells (0.5610
6) or elutriated primary human monocytes
(1610
6) were incubated with or without LPS (1 mg/ml)inpresence or
absence of CO (250 ppm) for indicated times. Culture supernatants
were collected at the indicated time points and the production of IL-
1b and IL-8 was analyzed with Quantikine ELISA kits purchased
from R&D system following the manufacturer’s instructions.
Nuclear Run-On Assay
THP-1 cells (2610
7) were treated with or without LPS (1 mg/
mL) in the presence or absence of 250 ppm CO for various times.
Figure 1. Volcano plot of changes in gene expression. (A) LPS
effect compared to control; probesets meeting criteria for LPS
upregulation are shown in red. (B) CO effect on LPS exposed cells;
again, probesets upregulated by LPS are shown in red. (C) CO effect on
the subset of genes that were upregulated by LPS; probesets meeting
criteria for CO suppression are shown in blue. THP-1 cells were treated
with or without LPS (1 mg/ml) in the presence or absence of CO
(250 ppm) for 1 h. LPS-induced genes were selected based on FDR
#10% and fold change $2. CO-suppressed genes required FDR #20%
and fold change #0.83. Some genes are represented by more than one
probe on these plots. Raw p-values for the comparison of interest are
plotted on the y-axes. Fold changes (x-axes) are the log mean 6 SEM of
four independent experiments.
doi:10.1371/journal.pone.0008139.g001
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reverse transcriptase reactions were carried out at 30uC for 40 min
in 250 mL of transcription buffer containing nuclei. Total RNA
was extracted (Qiagen) and newly synthesized RNA transcripts
were isolated using a mMACS Streptavidin kit (Miltenyi Biotech,
Aubum, CA) as previously described [33]. Nascent IL-1b
transcripts were quantified by qRT-PCR and normalized to
GAPDH.
Quantitative Real-Time PCR (qRT-PCR)
THP-1 cells (2610
6) or elutriated primary human monocytes
(3610
6) were incubated with or without LPS (1 mg/ml) in presence
or absence of CO (250 ppm) for indicated times. Total RNA was
isolated from treated cells using RNeasy Mini kits (Qiagen).
Reverse transcription was performed with RT kits (La-Roche,
Basel Switzerland). Transcript levels of selected genes were
measured by qRT-PCR using TaqManH Universal PCR master
mix and the ABI Prism 7900 sequence detection system (Applied
Biosystems, Foster City, CA). The gene specific primers and
probes for qRT-PCR were purchased from Applied Biosystems.
Target gene mRNA levels were normalized to the housekeeping
gene GAPDH and relative gene expression was calculated as fold-
induction compared with control [34].
Western Blotting
CO effects on MAPK pathways and IkBa in LPS-stimulated
THP-1 cells (2610
6) or elutriated primary human monocytes
(8610
6) were determined by Western blotting. Cells were rinsed
with cold PBS, and sonicated in 40 ml of mammalian protein
extraction reagent (Pierce) with Complete Mini Protease inhibitor
cocktail (Roche, Nutley, NJ). Protein concentrations were
estimated by BCA method (Pierce). Proteins (40 mg) were
separated on 4–20% SDS Tris-glycine gel (Invitrogen) in 1x
SDS Tris-Glycine running buffer, transferred to membranes,
blocked with 2% ECL Advance blocking reagent (Amersham
Biosciences, Pittsburg, PA) for 1 h at room temperature, and
Figure 2. CO downregulation of LPS-induced IL-1b and IL-8 protein. CO downregulated LPS-induced production of (A) IL-1b and (B) IL-8 in
THP-1 cells (p,0.02 for both), and likewise (C) IL-1b and (D) IL-8 in primary human monocytes (p #0.02 for both). THP-1 cells (0.5610
6) or primary
human monocytes (1610
6) were incubated with LPS (1 mg/ml) in the absence or presence of CO (250 ppm) for 2 h. Cytokine production was
measured in supernatants by ELISA. Results are mean 6 SEM of at least four independent experiments for THP-1 cells and seven healthy blood
donors for primary monocytes.
doi:10.1371/journal.pone.0008139.g002
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appropriate peroxidase-conjugated secondary antibody for 1 h at
room temperature. Signal was developed using ECL Advance
Western blotting detection kit (Amersham Biosciences) and
analyzed using the Image Station 440 charge-coupled device
camera system (Eastman Kodak Co., New Haven, CT, USA).
Membranes were subsequently stripped using standard stripping
solution (100 mM 2-mercaptoethanol, 2% SDS and 62.5 mM
Tris.HCl, pH 6.8) at 37uC for 30 min and reprobed with antibody
targeting total p38 or a-Tubulin to confirm equal loading of
samples.
Electrophoretic Mobility Shift Assay (EMSA)
Nuclear protein extracts from THP-1 cells (1610
7 ) or elutriated
primary human monocytes (2610
7) treated with and without LPS
(1 mg/ml) in the presence or absence of CO (250 ppm) were
prepared using CelLytic Nuclear Extraction kit (Sigma, St Louis,
MO), according to the manufacturer’s recommendations. Double
stranded DNA oligonucleotides containing NF-kB consensus
sequence (GGGGACTTTCCC) was labeled using Biotin 39-End
DNA Labeling kit (Pierce, Rockford, IL). NF-kB binding activity
was determined using the Light Shift Chemiluminesencent EMSA
kit (Pierce, Rockford, IL). Nuclear protein extract (5–10 mg) was
incubated for 40 min at room temperature in binding buffer
containing 200 ng poly dI:dC, 1% NP-40 and 50% glycerol with
labeled probe. For competition assays, 100-fold excess of unlabeled
NF-kB probe or its mutant probe was added 20 min prior to
labeled probe. For supershift assay, 2 mg of rabbit polyclonal
antibody against NF-kB p65 or p50 (Santa Cruz Biotechnology)
were incubated with nuclear extract 20 min prior to adding
labeled probe; likewise antibody against Ah Receptor (C-18) was
used as a negative control for NF-kB supershift. Protein-DNA
complexes were separated by electrophoresis on 4–20% Tris-
Borate-EDTA (TBE) native polyacrylamide gels (Invitrogen)
containing 0.5x Tris-Borate-EDTA running buffer at 4uC.
Chemiluminescence was measured using the Image Station 440
charge-coupled device camera system (Eastman Kodak).
Statistical Analysis
Data are presented as mean 6 SEM of at least three
independent measurements. Fold changes in Table 1 are
expressed as point estimates with a confidence interval of one
standard error. Messenger RNA and protein expression levels
were analyzed by analysis of variance (ANOVA) using experiment
as a blocking factor to control for experiment-to-experiment
variability. Direct group comparisons of particular interest were
examined by post hoc least squares means contrasts or paired t-tests.
Two- and three-factor ANOVAs were implemented when direct
tests of interacting factors were necessary. Differences were
considered statistically significant at the a=0.05 level.
For microarray data, expression intensities for each probeset
were computed as MAS5 signal intensities, and subsequently
quantile-normalized and transformed to homogeneous variance
using the ‘‘S10’’ transform available in the MSCL Analyst’s
Toolbox (http://abs.cit.nih.gov/MSCLtoolbox/). ANOVA was
carried out on the transformed values, accounting for batch (factor
1) and 4 distinct treatments (factor 2). The empirical Bayes method
of pooling residual variance across many probesets was employed
to increase the power of the ANOVA, as implemented in JMP-
Genomics (SAS, Inc, Cary, NC). Post-hoc contrasts of LPS vs.
control and LPS-CO vs. LPS were computed. A composite p-
value for the event that both LPS increased and LPS-CO
subsequently decreased the expression levels, was computed as
follows: p-both events = (max (p1,p2))
2, where p1 and p2 are the
Figure 3. CO suppression of LPS-induced IL-1b transcription,
mRNA expression, and protein production. (A) Nuclear run-on
assays in THP-1 cells (2610
7)s h o w e dt h a tC Or e p r e s s e sI L - 1 b
transcription by almost 98% within 30 min of LPS stimulation
(p=0.001) and the effect decreased to 67% at 60 min (p=0.01). (B) A
time course analysis of IL-1b mRNA expression in THP-1 cells (2610
6)b y
qRT-PCR showed that CO strongly suppressed LPS-induced IL-1b mRNA
by more than 90% within 30 min of exposure (p,0.0001), an effect that
was no longer present at 4 h. (C) Time course analysis of IL-1b protein
production in THP-1 cells (0.5610
6) showed maximum suppression of
CO on LPS-induced IL-1b at 2 h (p=0.04). Results are mean 6 SEM of
three independent experiments.
doi:10.1371/journal.pone.0008139.g003
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the events is assumed. This approximate p-value was then adjusted
for multiple comparisons using the Benjamini-Hochberg approach
to false discovery rate (FDR) [35].
Selection criteria for LPS-induced genes at 1 h were FDR
#10% and fold change (FC) $2, which returned 169 probesets
representing 101 genes. Gene selection cutoffs for CO-suppression
were chosen to capture a large enough list of genes for meaningful
bioinformatic analyses and thereby allow us to explore mecha-
nisms underlying this response. A review of the literature and
preliminary PCR testing of known CO-target genes demonstrated
CO to have modest, but reproducible effects on important
inflammatory response genes at the very early time point of
interest. These considerations led to the use of liberal criteria for
CO-suppression, namely FDR #20% and $1.2 fold downregu-
lation (corresponding to FC #0.83), which returned 79 genes.
Transcription factors were identified among differentially
expressed genes using GenomatixH Bibliosphere (Munich, Ger-
many), a text mining database derived from published articles.
One additional transcription factor was found using PubMed. NF-
kB target genes were similarly first sought using GenomatixH
Bibliosphere. Gene promoters from our entire list of CO-
suppressed transcripts were also subjected to a sequence-based
analysis using Biobase (http://www.biobase-international.com) to
identify additional genes with putative NF-kB binding sites.
Manual searching of PubMed citations retrieved two NF- kB
target genes that were not found by the other methods.
Results
Microarrays
Oligonucleotide microarrays identified a genome-wide set of
LPS-induced genes that were suppressed by CO at 1 h in THP-1
cells, a human monocytic cell line. In the absence of LPS, CO had
littleornoeffecton gene expression.Only two genes ofquestionable
relevance (putative binding protein 7a5 and uncharacterized gastric
protein ZG33P) were identified as CO-suppressed in the absence of
LPS, using liberal selection criteria (FDR #20% and FC #0.83). At
1 h, LPS primarily upregulated gene expression as illustrated by the
marked asymmetry of Figure 1A. Likewise, the predominant effect
of CO was to suppress these LPS-induced genes (Figure 1B). Of 101
genes (162 probesets) induced by LPS (FDR #10%, FC $2), CO
suppressed the expression of 78% (79 unique genes, 120 probesets),
using a liberal selection criteria (FDR #20% and FC #0.83) to
avoid missing important CO effects (Figure 1C). Notably, neither of
the two genes that were marginally suppressed by CO in the
absence ofLPSweresignificantlysuppressed inthepresenceofLPS.
OfLPS-inducedgenessuppressedbyCO,19%(15/79)wereknown
transcription factors including several EGR family members (Table
S1). Inflammatory response genes such as cytokines (IL-1b and
TNF-a), chemokines (macrophage inflammatory protein 3 alpha
[MIP-3a or CCL20], regulated upon activation, normal T-cell
expressed and secreted [RANTES or CCL5], chemokine ligand -1
[CXCL1], CXCL3 and CXCL8 [IL-8]), and inflammatory
pathway enzymes (prostaglandin-endoperoxide synthase-2 [PTGS2
or COX2] and phosphodiesterase 4B [PDE4B]) were also
prominent among CO-suppressed transcripts (see Table S1 for a
complete list). Some of these genes had not been previously
identified as targets of CO suppression, including EGR3, EGR4,
CXCL1, CXCL3, CCL3, CCL20, pentraxin-related gene (PTX3),
TNF alpha-induced protein 3 (TNFAIP3), activating transcription
factor 3 (ATF3), nuclear factor of kappa light chain gene enhancer
in B-cells (NFKBIA or IkB-alpha), micro RNA-155 (miR-155) and
PDE4B. See Table S1 for all newly identified CO-suppressed genes.
Validation of CO Effects in THP-1 Cells and Primary
Human Monocytes
Twenty CO-suppressed transcripts identified by microarray
were confirmed in THP-1 cells using qRT-PCR. Elutriated
monocytes from normal volunteers were also studied by qRT-
PCR to determine whether CO suppressed a similar set of LPS-
induced genes in primary cells. For THP-1 cells, qRT-PCR
compared to microarray results was directionally concordant for
all 20 genes. Nineteen of 20 transcripts independently met criteria
as significantly CO-suppressed by qRT-PCR (p,0.05, ANOVA
post hoc contrast of LPS+CO vs. LPS; Table 1). Like THP-1 cells,
elutriated primary human monocytes were challenged with LPS
for 1 h in the presence or absence of CO gas (250 ppm). For
primary human monocytes, 19 of these 20 genes were directionally
concordant with the microarray results in THP-1 cells and these
same 19 were individually confirmed as significantly CO-
suppressed (p,0.05, ANOVA post hoc contrast of LPS+CO vs.
LPS; Table 1).
For validation at the protein level, two secreted genes (IL-1b
and IL-8) were chosen for further evaluation. As expected,
treatment with LPS (1 mg/ml) increased IL-1b and IL-8
production at 2 h and exposure to CO (250 ppm) significantly
down-regulated this response in both THP-1 cells (p,0.02 for
both, paired t-test; Figure 2, A and B, respectively) and primary
human monocytes (p,0.02 for both, paired t-test; Figure 2, C and
D, respectively).
Figure 4. CO activation of stress kinases. THP-1 cells (2610
6) were treated (A) with different doses of CO gas (0–250 ppm) for 1 h or (B) with
250 ppm CO gas for various time points (0–2 h). Whole cell lysates (40 mg) were examined for phosphorylated p38 MAPK, ERK1/2 and Akt by Western
blotting. Total p38 MAPK showed equal loading and transfer of protein. Results shown are representative blots from three independent experiments.
doi:10.1371/journal.pone.0008139.g004
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Next, a time course of IL-1b transcription and protein
expression was evaluated in THP-1 cells using qRT-PCR. CO
suppression of IL-1b, a prototypic inflammatory response gene,
was found to be both early and transient. Nuclear run-on assays
demonstrated that CO suppressed IL-1b transcription by 98% at
30 min after LPS stimulation (p=0.001), and by 67% at 1 h
(p=0.01, ANOVA post hoc contrast of LPS+CO vs. LPS;
Figure 3A). Consistent with these effects on transcription, CO
suppressed LPS-induced IL-1b mRNA expression by 96% at
30 min, (p,0.0001; Figure 3B). Again, the size of this effect
decreased over time and CO no longer suppressed IL-1b mRNA
4 h after LPS exposure. Similarly, a time course of IL-1b protein
secretion showed a reduction in the CO effect from 69%
suppression at 2 h to only 20% at 6 h (p=0.1, Cochran-Armitage
test of linear trend; Figure 3C).
CO Effects on Stress Kinase Pathways in THP-1 Cells
The immediate onset and rapid decay of CO suppression was
similar in pattern to the manner in which LPS-TLR4 signaling
activates major stress kinase pathways. Given their importance in
LPS-induced gene expression and previous reports linking CO
suppression of inflammation to these pathways, the modulation of
stress kinases was explored experimentally. CO activated p38
MAPK, pERK1/2 and Akt at 30 min as determined by
phosphorylation in a dose (Figure 4A) and time (Figure 4B)
dependent manner. CO main effects (p,0.02 for all) were additive
with those of LPS for each kinase (p,0.001 for an LPS main
effect; p.0.12 for a LPS*CO interaction; Figure 5, A–C). In
contrast, CO exposure (250 ppm) did not directly activate JNK
(Figure 6A), but rather delayed the early phase of LPS-induced
JNK phosphorylation in THP-1 cells (Figure 6B). At 1 h, LPS-
induced JNK activation in the presence of CO reached the same
intensity as the maximum effect of LPS alone (seen at 30 min),
even as the LPS-only response began to wane.
Despite these effects of CO on kinase pathways, CO suppressed
LPS induction of IL-1b in the absence (p#0.04 for all) and
presence (p#0.055 for all) of specific kinase inhibitors (Figure 7,
A–D). Inhibitors of p38 MAPK, ERK1/2, and JNK all failed to
prevent or significantly decrease CO suppression of IL-1b
induction by LPS (p$0.18 for an interaction between CO
suppression and any of these three inhibitors; Figure 7, A, B and
C). Interestingly, Akt inhibition increased LPS induction of IL-1b,
while CO suppression became proportionally larger (p=0.04 for
an interaction between CO and the Akt inhibitor; Figure 7D). Akt
inhibitor-mediated increases in CO suppression suggest that CO
activation of Akt may actually interfere slightly with CO
suppression of inflammation. Collectively, inhibitor experiments
provided no evidence indicating that any of these kinase pathways
are primarily responsible for CO suppression of inflammation.
Association of CO Suppression with NF-kB Signaling
In addition to stress kinase pathways, LPS-TLR4 signal
transduction leads to MyD88-dependent, early phase and
MyD88-independent late phase activation of NF-kB. Ingenuity
PathwayH analysis identified the canonical NF-kB pathway as
significantly over-represented in our microarray list of CO-
suppressed genes (p,0.001). Of 79 immediate-early genes
suppressed by CO, 67% (53/79) had NF-kB binding sites in their
promoters based on an analysis using GenomatixH Bibliosphere. A
sequence-based promoter analysis of our CO-suppressed genelist
using Biobase (http://www.biobase-international.com) found that
54% (43/79) had putative NF-kB binding sites (p#0.03;
hypergeometric test comparing the genelist vs. 562 human
Figure 5. CO activation of LPS-induced stress kinases. CO and
LPS activated (A) p38 MAPK, (B) ERK1/2, and (C) Akt as measured by
Western blotting. (D) Total p38 served as a loading control. CO and LPS
effects for all three kinases were additive. THP-1 cells (2610
6) were
treated with or without LPS (1 mg/ml) in the presence or absence of CO
gas (250 ppm) for 1 h. Densitometric analysis is plotted as fold change
from control. Results shown are mean 6 SEM of three independent
experiments along with representative blots.
doi:10.1371/journal.pone.0008139.g005
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five NF-kB regulated genes not recognized by GenomatixH, two of
which were also not identified to have NF-kB binding sites by
Biobase. Overall 81% (64/79) of CO-suppressed genes were NF-
kB targets as determined by one or more of the above approaches
(Table S1).
Both THP-1 cells and primary human monocytes were used to
directly test the association of CO suppression with NF-kB
signaling as suggested by the microarray results. CO was found to
block an early step in LPS-induced NF-kB activation. Cytoplasmic
and total cell protein extracts were analyzed by Western blotting
for total IkBa and IkBa phosphorylated at serine residues 32 and
36. LPS exposure induced the rapid (within 15 min) phosphory-
lation and degradation of IkBa in both THP-1 cells (p,0.0001 for
both processes; Figure 8, A and B) and elutriated primary human
monocytes (p=0.003 and p,0.0001, respectively, ANOVA post
hoc contrast of LPS vs. control for each; Figure 8, C and D).
Conversely, CO inhibited LPS-induced IkBa phosphorylation
(p=0.002) and degradation (p=0.004) in THP-1 cells (Figure 8, A
and B, respectively). Similar effects of CO on IkBa phosphory-
lation (p=0.016) and degradation (p=0.001) were also docu-
mented in primary human monocytes (Figure 8, C and D,
respectively), showing that this mechanism of action was not
limited to an idiosyncratic cell line.
IkBa phosphorylation and degradation frees NF-kB from
sequestration, allowing it to translocate to the nucleus, bind to
target promoters, and turn-on transcription. LPS stimulation
caused NF-kB p65 translocation from the cytoplasm to the nucleus
while CO interfered with this effect in THP-1 cells (p=0.002;
Figure 9A) and primary human monocytes (p=0.002; Figure 9B),
as seen by Western blotting.
EMSA were performed using nuclear extracts from THP-1 cells
and primary human monocytes to further demonstrate CO effects
on NF-kB signaling. As expected, LPS increased the formation of
a protein complex with NF-kB consensus sequence probe. CO
exposure reproducibly reduced NF-kB complex formation in both
THP-1 cells and primary human monocytes (p=0.001 and
p=0.002; Figure 9, C and D, respectively). Experiments were
carried out with 100-fold molar excesses of unlabeled specific
probe that competed with NF-kB binding and mutant probe that
did not, demonstrating the sequence specificity of NF-kB bands.
Finally, anti-p65 and anti-p50 antibody super-shifted and/or
diminished the density of NF-kB-protein complexes in both THP-
1 cells and primary human monocytes (Figure 9, C and D,
respectively) confirming the presence of these proteins. An
irrelevant anti-Ah Receptor (C-18) antibody, used as negative
control, did not alter the LPS-induced NF-kB complexes (Figure 9,
C and D, respectively).
Discussion
CO has been linked to vascular health and identified as a
cytoprotective messenger in lung injury. This has led to
speculation about the potential therapeutic benefits of CO in
septic shock and pulmonary inflammation. However, most
mechanistic and therapeutic research on CO has been performed
in rodent models of inflammation and tissue injury. This has
importantly advanced several mechanisms of CO action, identified
a number of downstream gene targets, and shown beneficial effects
of CO in models of ischemia reperfusion injury [13], transplant
rejection [36], ventilator-induced lung injury [37] and septic shock
[7,38]. Exploration of CO signaling in human cells suggests
extensive overlap with findings in rodents, yet a recent study in
endotoxin challenged volunteers failed to detect clinically
important anti-inflammatory effects in vivo [32].
Here microarrays were used to more globally characterize the
effects of CO on the early LPS- induced inflammatory response of
human cells. Although conducted in THP-1 cells, a monocytic cell
line, many CO-suppressed genes were subsequently confirmed in
primary human monocytes. CO was found to broadly suppress
LPS-induced immediate-early genes that initiate and propagate
inflammation including pivotal transcription factors (e.g. EGR
family members and ATF3), cytokines (e.g. IL-1b and TNF-a) and
chemokines (CCL5, CXCL1 and IL-8). Using IL-1b as a
prototypic target gene, CO suppression of transcription was found
to be very fast, but transient, a response pattern reminiscent of
Figure 6. CO effects on LPS-induced JNK activation. (A) Effects of CO and LPS alone on JNK activation. (B) Time-kinetics of LPS (1 mg/ml)
induced JNK activation evaluated in the presence or absence of CO (250 ppm). Zero to 10 min and 15 min to 1 h were run at the same time, but on
separate gels. Whole cell lysates (40 mg) from THP-1 cells (2610
6) were examined for phosphorylated JNK by Western blotting. a-Tubulin
demonstrated equal loading and transfer of protein. Results shown are representative blots from at least two independent experiments.
doi:10.1371/journal.pone.0008139.g006
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ERK1/2 and Akt and perhaps more importantly delayed LPS-
induced JNK activation, inhibitors of these kinase pathways failed
to substantially block CO suppression as measured by effects on
IL-1b. An analysis of CO suppressed genes revealed that most
were transcriptionally regulated by NF-kB. Like the stress kinase
pathways, NF-kB is a target of MyD88-dependent early phase
LPS-TLR4 signaling. CO was subsequently shown to significantly
block an early step in LPS-induced NF-kB activation. Collectively
our findings support a mechanism for the anti-inflammatory
actions of CO that targets a proximal step in LPS-TLR4 signal
transduction, before the divergence of the JNK and NF-kB
pathways.
The genome-wide effects of CO on gene expression have not
been previously investigated in human monocytes. Our experi-
mental design focused on early gene regulation downstream from
LPS-TLR4 signal transduction. Using this approach many genes
previously reported to be CO responsive either in mouse or
human cells were also identified here such as TNF-a [7,37], MIP-
b [7], IL-1b [7,18], IL-8 [21], ICAM-1 [16] and COX-2 [39]. In
addition to these known CO target genes, new CO-responsive
transcripts were detected for the first time by microarray including
CCL3, CXCL1, CXCL3, PTX3, PDE4B, NFKBIA, ATF3, EGR
family members other than EGR1, miR-155 and TNFAIP3. CO
suppression of numerous chemokines beyond those initially
described indicates an ability of CO to broadly modulate
chemotaxis and cell recruitment, early events in establishing a
local inflammatory response. PTX3, another novel CO target, is
produced at sites of infection by macrophages and has been
implicated in acute lung injury [40]. PDE4B, also newly
discovered here as a CO-suppressed gene is the only known
LPS-inducible PDE4 subtype and ablation of this gene protects
mice from LPS-induced shock [41]. EGR family members are
zinc-finger transcription factors associated with ischemia/reperfu-
sion injury [17]. While EGR-1 was already a recognized CO-
target, the finding that CO-suppresses multiple family members
suggests a more general role in regulating vascular inflammation
due to ischemia [26,42].
In addition to decreasing the expression of proinflammatory
genes, CO also suppressed several transcripts associated with
negative feedback mechanisms that control the intensity of
immune responses. LPS-TLR4-NF-kB signaling is known to
induce miR-155, a microRNA that acts like a brake on
inflammation [43]. CO suppression of miR-155 might therefore
intensify the response to LPS. Similarly CO also suppressed
TNFAIP3, a proapoptotic protein that terminates TLR-induced
NF-kB activition and inflammatory gene induction in macro-
phages [44]. As such, CO suppression of miR-155 and TNFAIP3
could be proinflammatory and allow early phase inhibition of NF-
kB signaling by CO to recover. Interestingly, using IL-1b as a
protypic gene, CO suppression was found to be transient. In fact,
by 4 h after LPS challenge, IL-1b mRNA levels were slightly
higher in CO exposed cells. The time dependent loss of CO anti-
inflammatory effects has not been reported previously. However,
this finding may have implications for the therapeutic application
of CO in patients.
We found that CO activated p38 MAPK, ERK1/2 and Akt,
but delayed LPS-induced JNK activation in human monocytes.
Other investigators have previously identified one or more of these
stress kinase pathways as central to the anti-inflammatory effects of
CO. LPS-challenged murine macrophages or mice [7] precondi-
tioned with low dose CO gas showed reductions in the production
of TNF-a, IL-1b and MIP-1b and increases in IL-10 that were
mediated by p38 MAPK. Mice deficient in MKK3, an upstream
Figure 7. Effects of CO on LPS-induced IL-1b production in the
presence or absence of stress kinase inhibitors. THP-1 cells
(2610
6) were pretreated with inhibitors of (A) p38 MAPK (SB202190;
0.1 mM), (B) ERK1/2 (PD98059; 30 mM), (C) JNK (Inhibitor II; 10 mM), and
(D) Akt (LY294002; 10 mM) for 30 min and then stimulated with LPS
(1 mg/ml) in the presence or absence of CO gas (250 ppm) for 2 h.
DMSO (0.1%) vehicle was used as control. IL-1b production was
measured in supernatants by ELISA. Results are mean 6 SEM of three to
five independent experiments.
doi:10.1371/journal.pone.0008139.g007
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IL-10 in response to CO after LPS challenge. In our experiments,
CO effects were additive with LPS in activating p38 MAPK, but
unlike the mouse experiments, inhibiting p38 MAPK did not block
CO suppression of IL-1b. In addition to p38 MAPK activation,
CO inhibition of ERK1/2, an effect opposite to our results in
human monocytes, has been associated with the suppression of
inflammation. In human pulmonary epithelial cells, IL-17
induction of IL-6 was reduced by CO through interference with
ERK1/2 activation [29]. Consistent with these findings, another
group demonstrated that CO protection from ischemic lung injury
in rats was mediated by the inhibition of ERK activation and
subsequent EGR-1 induction [17]. Interestingly, CO inhibition of
ERK1/2 in rats was cGMP dependent. In our human monocyte
study, CO suppression of early LPS-induced genes was cGMP
independent (data not shown), ERK1/2 was activated rather than
inhibited by CO, and ERK blockade did not alter the CO effect.
Although we found that CO activated Akt in human monocytes,
unlike a study of cardiac ischemia/reperfusion injury in rats [45],
inhibition of this pathway enhanced rather than attenuated the
impact of CO. We like others, found that CO delayed LPS-
induced JNK activation. It was shown in mouse macrophages that
delay of JNK activation by CO reduced LPS induction of IL-6
through effects at an AP-1 promoter-binding site [18]. CO-
mediated delay of JNK activation is consistent with a proximal
disruption in LPS-TLR4 signal transduction that could alter the
kinetics of gene expression. However, this mechanism was not
essential for IL-1b suppression by CO. Notably, CO effects on
JNK have also been associated with cytoprotection from apoptosis
[46], an important function of CO that was not examined in the
current investigation.
An in silico analysis of our microarray results suggested that the
canonical NF-kB pathway might be a pivotal effector of CO
suppression in human monocytes. NF-kB is held dormant in the
cytoplasm of resting cells by IkB. LPS challenge leads to the rapid
phosphorylation and degradation of IkB, allowing NF-kBt o
translocate to the nucleus, where it binds to promoters and
activates the transcription of inflammatory response genes
[44,47,48]. A role for NF-kB in CO suppression is supported by
previous studies in murine macrophages [19], human umbilical
vein endothelial cells [30], and Caco-2 cells [21], a human colonic
adenocarcinoma line. CO inhibition of NF-kB activation has been
associated with the suppression of a number of genes including
GM-CSF [19], iNOS, ICAM-1[16], IL-8, IL-6 and MMP-7 [21].
While CORM-2 was shown to attenuate NF-kB activation in the
livers of septic mice, another in vivo study of inhaled CO found no
effect on NF-kB activation in rat liver allografts [49]. Two other
investigations studying the anti-apoptotic activity of CO have
Figure 8. CO prevention of LPS-induced IkBa phosphorylation and degradation. (A) Phosphorylated IkBa in THP-1 cells, (B) total IkBa in
THP-1 cells, (C) phosphorylated IkBa in primary human monocytes, and (D) Total IkBa in primary human monocytes. Whole cell extracts or
cytoplasmic fractions were prepared from THP-1 cells (2610
6) and elutriated primary human monocytes (5610
6), treated with or without LPS (1 mg/
ml) in the presence or absence of CO (250 ppm) for 15 min and examined for phosphorylated or total IkBa by Western blotting. a-Tubulin served as a
equal loading and transfer control. Densitometry results are shown as the means 6 SEM of three independent experiments.
doi:10.1371/journal.pone.0008139.g008
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PLoS ONE | www.plosone.org 10 December 2009 | Volume 4 | Issue 12 | e8139Figure 9. CO inhibition of LPS-induced NF-kB nuclear translocation and activation. CO inhibited LPS-induced nuclear translocation of NF-
kB from the cytoplasm (A) THP-1 and (B) primary human monocytes as shown by Western blotting using antibodies against p65. Cytoplasmic
fractions were made by treating the cells with or without LPS (1 mg/ml) in presence or absence of CO (250 ppm) for 30 min. Nuclear extracts were
prepared to measure NF-kB DNA binding by EMSA in (C) THP-1 cells and (D) primary human monocytes using NF-kB probe. Supershift of the LPS-
induced NF-kB complex is shown using anti-p65 and anti-p50 antibodies, while anti-Ah Receptor (C-18) antibody served as a negative control. THP-1
cells (1610
7) and primary human monocytes (2610
7) were stimulated with or without LPS (1 mg/ml) in the presence or absence of CO (250 ppm) for
30 min. Densitometry results are shown as the means 6 SEM of three independent experiments. Results are representative gels from at least three
experiments.
doi:10.1371/journal.pone.0008139.g009
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and mouse, cow and human endothelial cells [23]. Nonetheless,
CO (250 ppm) was shown in our experiments to reproducibly
disrupt IkBa phosphorylation and degradation, and subsequent
NF-kB activation in LPS-stimulated human monocytes.
Although CO interference with LPS-TLR4 activation of NF-kB
appears to be a pivotal event in the early suppression of gene
transcription, the exact mechanism and molecular target(s) of this
effect are not entirely clear. Immediate events in LPS-TLR4 signal
transduction include the recruitment of adaptor proteins such as
MyD88. The MyD88-dependent arm of LPS-TLR4 signaling
culminates in the rapid-phase activation of NF-kB and stress
kinase pathways. In parallel, the MyD88-independent pathway
leads to a slightly later phase of NF-kB activation. Nakahira and
colleagues have reported in murine RAW264.7 cells compelling
results demonstrating that CO disrupts the recruitment of essential
adaptor proteins, specifically MyD88 and TRIF, to the TLR4
receptor complex, thereby reshaping LPS signal propagation [20].
Alterations in these very early LPS-TLR4 signaling events seem
like a plausible explanation for both the brief delay in JNK
activation and interference with NF-kB-mediated gene induction.
Given the regulatory complexity, it also seems likely that changes
in the kinetics of adaptor protein recruitment might produce a
variety of stress kinase pathway effects depending on the specific
cellular context.
CO was shown to suppress immediate-early gene induction in
LPS challenged human monocytes. CO activated several stress
kinase pathways, while LPS-induced JNK activation was delayed
and NF-kB signaling was impaired. Future investigations should
focus on early events upstream from NF-kB and stress kinase
pathway activation, as well as clinical studies to determine the
utility of CO-based therapies in the management of acute
inflammation. Our results would suggest that the greatest benefits
of CO might be realized in situations where the inflammatory
challenge is predictable and brief such as cardiac bypass or
ischemia/reperfusion in transplant surgery.
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